Mariner Finance p.l.c. – New Bond Issue

Mariner Finance p.l.c. (the “Issuer”), is pleased to announce the issue of €44,000,000 Unsecured bonds at 5% at a nominal value of €100 per bond, redeemable in 2032 (the “Bond Issue”), following approval by the Listing Authority.

The New Bonds shall be made available for subscription as follows:

  • an amount of up to €35,000,000 in nominal value of New Bonds shall be made available for subscription by those persons who, as at 11 November, 2022, held 5.3% unsecured bonds having a nominal value of €100 per bond and redeemable on 3 July, 2024 (ISIN MT0000271214), issued by the Company pursuant to a prospectus dated 2 June, 2014 (the “Existing Bonds”), and who elect to subscribe for Bonds by surrendering the corresponding amount of Existing Bonds in favour of the Company. A premium amounting to €1.50 per Existing Bond surrendered as aforesaid shall be payable by the Company to the holders of Existing Bonds partaking in the proposed exchange of Existing Bonds for New Bonds; and

  • an amount of up to €9,000,000 in nominal value of New Bonds, as such amount would be increased by any amount not subscribed for by the holders of the Existing Bonds as indicated in (a) above, and therefore resulting in part of the amount referred to in (a) becoming available for distribution other than by way of exchangeable bond transfer, shall be made available for subscription by the holders of Existing Bonds applying for any New Bonds in excess of the amount corresponding to their holding of Existing Bonds, and the general public. Applications from the general public shall be subject to a minimum subscription amount of €2,000. No minimum subscription amount shall apply in respect of applications from holders of Existing Bonds.

Full details about this Bond Issue are set out in the Prospectus dated 21st November 2022 which can be found here.

MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later 12th December 2022. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.

If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.

For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.

_____

 

The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns.

Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material is intended only for the use of the recipient and shall not be reproduced in any way, whether in whole or in part, by the recipient. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.